General Information of the Compound
Compound ID
CP0498516
Compound Name
4-(5-Methyl-pyridazin-3-yl)-piperazine-1-carboxylic acid (6-fluoro-benzothiazol-2-yl)-amide
    Show/Hide
Structure
Formula
C17H17FN6OS
Molecular Weight
372.429
Canonical SMILES
Cc1cnnc(c1)N1CCN(CC1)C(=O)Nc1nc2ccc(F)cc2s1
    Show/Hide
InChI
InChI=1S/C17H17FN6OS/c1-11-8-15(22-19-10-11)23-4-6-24(7-5-23)17(25)21-16-20-13-3-2-12(18)9-14(13)26-16/h2-3,8-10H,4-7H2,1H3,(H,20,21,25)
    Show/Hide
InChIKey
ZKHMNVBOQDVEMA-UHFFFAOYSA-N
Physicochemical Property
logP
2.88792
Rotatable Bonds
2
Heavy Atom Count
26
Polar Areas
74.25
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44395917
ChEMBL ID
CHEMBL187484
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS